Mitochondrial dysfunction and Parkinson's disease: pathogenesis and therapeutic strategies

S Moradi Vastegani, A Nasrolahi, S Ghaderi… - Neurochemical …, 2023 - Springer
Parkinson's disease (PD) is a common age-related neurodegenerative disorder whose
pathogenesis is not completely understood. Mitochondrial dysfunction and increased …

[HTML][HTML] The impact of aerobic and resistance training intensity on markers of neuroplasticity in health and disease

T Hortobágyi, T Vetrovsky, GM Balbim… - Ageing Research …, 2022 - Elsevier
Objective To determine the effects of low-vs. high-intensity aerobic and resistance training
on motor and cognitive function, brain activation, brain structure, and neurochemical …

Targeting mitochondrial impairment in Parkinson's disease: challenges and opportunities

J Prasuhn, RL Davis, KR Kumar - Frontiers in cell and developmental …, 2021 - frontiersin.org
The underlying pathophysiology of Parkinson's disease is complex, but mitochondrial
dysfunction has an established and prominent role. This is supported by an already large …

The Hypoxia Response Pathway: A Potential Intervention Target in Parkinson's Disease?

JM Janssen Daalen, WJH Koopman… - Movement …, 2024 - Wiley Online Library
Parkinson's disease (PD) is a progressive neurodegenerative disorder for which only
symptomatic treatments are available. Both preclinical and clinical studies suggest that …

NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6A methylation through upregulation of …

X Gong, M Huang, L Chen - CNS neuroscience & therapeutics, 2024 - Wiley Online Library
Abstract Objective The feature of Parkinson's disease (PD) is the heavy dopaminergic
neuron loss of substantia nigra pars compacta (SNpc), while glutaredoxin (GLRX) has been …

Targeting mitochondria as a therapeutic approach for Parkinson's disease

M Abrishamdar, MS Jalali, Y Farbood - Cellular and molecular …, 2023 - Springer
Neurodegeneration is among the most critical challenges that involve modern societies and
annually influences millions of patients worldwide. While the pathophysiology of Parkinson's …

Physical exercise and mitochondrial function: new therapeutic interventions for psychiatric and neurodegenerative disorders

L Sun, T Liu, J Liu, C Gao, X Zhang - Frontiers in Neurology, 2022 - frontiersin.org
Psychiatric and neurodegenerative diseases, including major depression disorder (MDD),
bipolar disorder, and Alzheimer's disease, are a burden to society. Deficits of adult …

[HTML][HTML] Exercise protects synaptic density in a rat model of Parkinson's disease

KH Binda, TP Lillethorup, CC Real, SL Bærentzen… - Experimental …, 2021 - Elsevier
Background Parkinson's disease (PD) is characterized by Lewy body and neurite pathology
associated with dopamine terminal dysfunction. Clinically, it is associated with motor …

Exploring the mechanisms and therapeutic approaches of mitochondrial dysfunction in Alzheimer's disease: An educational literature review

MHED Moawad, I Serag, IM Alkhawaldeh… - Molecular …, 2024 - Springer
Alzheimer's disease (AD) presents a significant challenge to global health. It is characterized
by progressive cognitive deterioration and increased rates of morbidity and mortality among …

The emerging role of exercise in Alzheimer's disease: Focus on mitochondrial function

L Feng, B Li, SS Yong, Z Tian - Ageing Research Reviews, 2024 - Elsevier
Alzheimer's disease (AD) is an age-related neurodegenerative disease characterized by
memory impairment and cognitive dysfunction, which eventually leads to the disability and …